(Q33230629)

24 July 2017

Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses (English)

1 reference

24 July 2017

Ela Hunt

3

0 references

Lorraine M Work

object named as

Lorraine M Work

1

0 references

Stuart A Nicklin

object named as

Stuart A Nicklin

4

0 references

Michael Hallek

10

object named as

Michael Hallek

1 reference

24 July 2017

9

Uta Drebber

1 reference

24 July 2017

Hildegard Büning

2

1 reference

24 July 2017

Laura Denby

5

1 reference

24 July 2017

Nicola Britton

6

1 reference

24 July 2017

Kristen Leike

7

1 reference

24 July 2017

Margarete Odenthal

8

1 reference

24 July 2017

Andrew H Baker

11

1 reference

24 July 2017

4 January 2006

1 reference

24 July 2017

1 reference

24 July 2017

13

1 reference

24 July 2017

683-693

1 reference

24 July 2017

4

1 reference

Steps toward mapping the human vasculature by phage display.

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Molecular profiling of heart endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Identification of endothelial genes up-regulated in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Targeting the prostate for destruction through a vascular address

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Anti-cancer activity of targeted pro-apoptotic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Tumor targeting with a selective gelatinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Reversal of obesity by targeted ablation of adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Endothelium-targeted gene and cell-based therapies for cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Rescue and propagation of fully retargeted oncolytic measles viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Development of efficient viral vectors selective for vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

In vivo phage display to identify M cell-targeting ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

UniProt: the Universal Protein knowledgebase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

GoMiner: a resource for biological interpretation of genomic and proteomic data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2005.11.013

1 reference

24 July 2017

1 reference